Five Prime Therapeutics reported the appointment of Thomas Civik as President and Chief Executive Officer and a member of the Board of Directors of the company. Civik joins Five Prime from Foundation Medicine, where he served as Chief Commercial Officer. William Ringo, who has served as interim CEO since September 2019 and as Chairman of the Board, will step down as CEO and will continue as Chairman of the Board of Directors.